Evangelia A Papakonstanti

2PUBLICATIONS
1CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Mar 28, 2026
IOA-244, a novel p110δ PI3K inhibitor, blocks breast tumour progression on either mono- or combined-therapy.

Evangelia Goulielmaki, Anna Tsapara, Lydia Xenou

|Jan 05, 2024
A combined opposite targeting of p110δ PI3K and RhoA abrogates skin cancer.

Niki Tzenaki, Lydia Xenou, Evangelia Goulielmaki

Pageof 1

Frequent Collaborators